CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
Sang Ouk Chin, Cheol Ryong Ku, Byung Joon Kim, Sung-Woon Kim, Kyeong Hye Park, Kee Ho Song, Seungjoon Oh, Hyun Koo Yoon, Eun Jig Lee, Jung Min Lee, Jung Soo Lim, Jung Hee Kim, Kwang Joon Kim, Heung Yong Jin, Dae Jung Kim, Kyung Ae Lee, Seong-Su Moon, Dong Jun Lim, Dong Yeob Shin, Se Hwa Kim, Min Jeong Kwon, Ha Young Kim, Jin Hwa Kim, Dong Sun Kim, Chong Hwa Kim
Endocrinol Metab. 2019;34(1):53-62.   Published online March 21, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.1.53

Excel Download

Dose and frequency titration of somatostatin analogues in the treatment of acromegaly - an injection of expediency?
R. A. James, J. Gilroy
Clinical Endocrinology. 2001;54(1):11-13   Crossref logo
Link1 Link2 Link3
CURRENT VIEWS ON THE TREATMENT OF ACROMEGALY WITH SOMATOSTATIN ANALOGUES
I. A. Ilovaiskaya
Medical Council. 2017;(3)75-79   Crossref logo
Link1
Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues
Cecilia Follin, Sven Karlsson
Endocrine Connections. 2016;5(4):167-173   Crossref logo
Link1
Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues
Marinella Tzanela, Dimitra A. Vassiliadi, Nikolaos Gavalas, Andrea Szabo, Eleni Margelou, Athina Valatsou, Charalambos Vassilopoulos
Clinical Endocrinology. 2011;75(1):96-102   Crossref logo
Link1 Link2
Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly
Marco Losa, Jens Bollerslev
Endocrine. 2016;52(3):451-457   Crossref logo
Link1 Link2 Link3
Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists
Trevor A. Howlett, Debbie Willis, Gillian Walker, John A.H. Wass, Peter J. Trainer,
Clinical Endocrinology. 2013;n/a-n/a   Crossref logo
Link1
Somatostatin Octapeptide (SMS 201–995, Sandostatin®) in the Medical Treatment of Acromegaly
J. A. H. Wass, K. Davidson, S. Medbak, G. M. Besser
Sandostatin® in the Treatment of Acromegaly. 1988;151-152   Crossref logo
Link1
Medical Treatment of Acromegaly. Dopaminergic Agonists and Long-Acting Somatostatin
A. Liuzzi, P. G. Chiodini, R. Cozzi, D. Dallabonzana, G. Oppizzi, M. M. Petroncini
Sandostatin® in the Treatment of Acromegaly. 1988;75-79   Crossref logo
Link1
PDB34 MONITORING OF TREATMENT COSTS AFTER REIMBURSEMENT DECISION: SOMATOSTATIN ANALOGUES FOR ACROMEGALY
J Valentim, V Passos, A Calabró
Value in Health. 2008;11(6):A506-A507   Crossref logo
Link1 Link2
Combination treatment with somatostatin analogues and pegvisomant in acromegaly
S.J.C.M.M. Neggers, A.J. van der Lely
Growth Hormone & IGF Research. 2011;21(3):129-133   Crossref logo
Link1 Link2